Glycylcyclines

Origin and chemical structure

Glycylcyclines represent a fundamentally new class of antibacterial agents. Historically and chemically, they are closely related to the well-known tetracycline group. The first and main representative of this innovative group is the drug tigecycline. It was developed through chemical modification of an existing antibiotic, minocycline, and is therefore rightfully considered its direct derivative.

If we examine the spatial chemical structure of glycylcyclines in detail, we find the basic core characteristic of all classical tetracyclines. This core contains exactly four interconnected cyclic rings. It is this key structural feature that largely determines their pharmacological properties and obvious chemical affinity with their precursors.

Mechanism of antibacterial action

Based on its type of effect on the microbial cell, tigecycline is a strictly bacteriostatic drug. In clinical pharmacology, this means the antibiotic does not cause immediate bacterial death. Instead, it reliably halts further growth and active reproduction, giving the body's immune system the time needed to finally eradicate the pathogens.

At the core of this effect is a profound disruption of translation—the intracellular synthesis of bacterial protein. The drug has an exceptionally high affinity for the 30S subunit of the bacterial ribosome. By firmly binding to this structure, tigecycline acts as an insurmountable steric blocker. It physically closes the entrance to the A-site (aminoacyl center) of the ribosome.

Due to the formation of this block, the aminoacyl-tRNA molecule completely loses its ability to bind to the ribosome. As a direct consequence, the critical process of adding new amino acids is disrupted, and the growth of the polypeptide chain is immediately halted. Without continuous protein synthesis, the bacterial cell loses viability.

Spectrum of antimicrobial activity

Tigecycline is distinguished by a broad spectrum of activity. When analyzing its properties, it is important to clearly understand that the drug has no antifungal or bactericidal activity and definitely does not belong to narrow-spectrum antibiotics.

The confirmed spectrum of its activity includes the following microorganisms:

• Gram-positive cocci: the drug demonstrates high activity against Staphylococcus aureus. Crucially, tigecycline works successfully not only against methicillin-susceptible strains, but also effectively suppresses methicillin-resistant strains (MRSA). The spectrum of activity also includes various species of streptococci and enterococci (specifically, Enterococcus faecalis). However, activity against enterococci is retained exclusively for vancomycin-susceptible strains.
• Gram-negative flora: the drug reliably stops the growth of Escherichia coli (Escherichia coli).
• Anaerobic bacteria: tigecycline exhibits pronounced activity against bacteroids, primarily Bacteroides fragilis.

Clinical application

Given its potent antibacterial potential and broad spectrum of activity, including problematic resistant strains (such as MRSA), glycylcyclines are reserved for the treatment of serious conditions.

The main indications for prescribing tigecycline are:

1. Severe skin infections and underlying soft tissues.
2. Intra-abdominal infections (severe inflammatory processes in the abdominal cavity, where mixed flora, including Escherichia coli and bacteroids, are frequently encountered).

In terms of the route of administration, the drug is intended exclusively for parenteral use. It is administered intravenously, which guarantees the fastest possible achievement of necessary therapeutic concentrations in the systemic circulation.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Features of glycylcycline binding to the A-site of the ribosome
• Differences between glycylcyclines and classical tetracyclines
• Mechanisms of MRSA susceptibility to tigecycline
• Principles of therapy for severe intra-abdominal infections

Other topics in the section "Antibacterial Chemotherapeutic Agents"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.